Highlights

• Analysis of china pharmaceutical exports and internationalisation landscape 
• Reflections on pharmaceutical internalisation-export pathways for proprietary branded formulations
• Strategic considerations for peptide drug global expansion
• Collaborative internationalisation—advanced models for Chinese pharmaceutical companies "going global"
•  Leveraging Hong Kong and Macau advantages to bring Chinese innovative drugs to the world
• Exploration of API-formulation integration
• Discussion on globalization pathways for complex

Highlights 

• New breakthroughs in efficient, low-irritation functional skincare formulations
• Biomimetic lipids advancing barrier repair for sensitive skin
• Scientific skincare driving precise anti-aging solutions
• Antioxidant ingredients enabling effective whitening and anti-aging solutions
• Innovative applications of plant-based ingredients under natural, healthy, and environmentally friendly concepts

Highlights 

• How can DTP business stakeholders ensure compliance under stricter medical insurance supervision?
• Exploration and practice of internet healthcare platforms facilitating DTP prescription circulation
• New opportunities in the pharmaceutical market: jointly creating a blue ocean in the out-of-hospital market
• The surge in prescription circulation: new development opportunities for clinical agents/representatives
• How national negotiation, medical insurance, and self-pay products can expand in the out-of-hospital prescription circulation market?

Highlights

Compliance and Innovation Session:

•  Regulatory interpretation for injectable aesthetic products
• Market opportunities and challenges for international expansion
• Technological breakthroughs in recombinant collagen and aesthetic applications
• Challenges faced by traditional pharmaceutical companies entering the aesthetic medicine sector

Injectable Formulation Technology and Quality Control Session:

• Product positioning and differentiated development strategies: from market demands to technical implementation  
• Quality control of raw materials and crosslinking technology for hydro lifting injections 
• Pre-filled syringe solutions for aesthetic injectables
• Key quality control points and critical technologies for injectable aesthetic products 
• Comprehensive evaluation of clinical efficacy and safety for injectable cosmetic procedures

Synthetic Biology and Regenerative Materials Session:

• Core technology development in regenerative medicine: bone materials, stem cells, and stimulating factors
• Application of exotics in skin regeneration
• Innovation in aesthetic raw materials driven by synthetic biology
• Safety research experience of new materials from a full lifecycle perspective

Highlights 

The conference will deeply focus on three core dimensions: policy and regulations, production technology, and quality control, while integrating pharmaceutical industry development trends in the Greater Bay Area through three thematic sub-forums. Simultaneously, the meeting will invite regulatory experts, corporate executives, and technical pioneers to gather together, creating the pharmaceutical industry's first intelligent exchange platform that connects the entire chain of research and development, production, and quality control.